Western blot analysis of sorted iRFP-positive cells confirmed decreased levels of both KRAS and phosphorylated ERK in all cell lines (Figure 6B), indicating effective target engagement and suppression of downstream signaling in recipient cancer cells. The gene discussed is KRAS; the disease is cancer.